HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992

AIDS

Volumn 8, Issue 10, 1994, Pages 1465-1469

  Lehman, J Stan ^a   Allen, David M ^a   Green, Timothy A ^a   Onorato, Ida M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cocaine; Crack cocaine; Heroin; HIV seroprevalence; HIV surveillance; Injecting drug use; Non injecting drug use

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; CITY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

EID: 0028111189     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199410000-00014     Document Type: Article

References (19)

1. Allen DM, Onorato IM, Green TA: HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. Am J Public Health 1992, 82:541-546.
2. Hahn RA, Onorato IM, Jones TS, Dougherty J: Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989, 261:2677-2684.
3. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control and Prevention, October 1993:1-19.
4. Edlin BR, Irwin KL, Ludwig DD, et al.: High-risk sex behavior among young street-recruited crack cocaine smokers in three American cities: an interim report. J Psych Drugs 1992, 24:363-371.
5. Fullilove RE, Fullilove MT, Bowser BP, Gross SA: Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, California. JAMA 1990, 263:851-855.
6. Chiasson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW: Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991, 5:1121-1126.
7. Chirgwin K, DeHovitz JA, Dillon S, McCormack WM: HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. Am J Public Health 1991, 81:1576-1579.
8. Schottenfeld RS, O'Malley S, Abdul-Salaam K, O'Connor PG: Decline in intravenous drug use among treatment-seeking opiate users. J Substance Abuse Treatment 1993, 10:5-10.
9. Hartgers C, van den Hoek A, Krijnen P, van Brussel G, Coutinho RA: Changes over time in heroin and cocaine use among injecting drug users in Amsterdam, the Netherlands, 1985-1989. Br J Addict 1991, 86:1091-1097.
10. French JF, Mamo A: Drug abuse in Newark and New Jersey: an overview. In Epidemiologic Trends in Drug Abuse, Proceedings December 1993. Rockville: US Department of Health and Human Services, 1994:134-148.
11. Fennema JS, van den Hoek JA, Huisman JG, van den Akker R, Coutinho RA: HIV prevalence among non-injecting Surinamese drug users in Amsterdam. IX International Conference on AIDS. Berlin, June 1993 [abstract PO-C15-2922].
12. Patel R, Brandon D, Altman R, Robeson L, Pizzuti W: HIV-1 infection among non-IVDAs admitted to drug treatment programs. IX International Conference on AIDS. Berlin, June 1993 [abstract FC560].
13. Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W, Hulley SB: HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 1994, 271:515-518.
14. Dondero TJ, Pappaioanou M, Curran JW: Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program. Public Health Rep 1988, 103:213-220.
15. Pappaioanou M, Dondero TJ, Petersen LR, Onorato IM, Sanchez CD, Curran JW: The Family of HIV Seroprevalence Surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep 1990, 105:113-119.
16. Centers for Disease Control and Prevention: National HIV Serosurveillance-Summary of Results Through 1992. Atlanta: Centers for Disease Control and Prevention; 1994, 3:1-51.
17. Jones TS, Allen DM, Onorato IM, Petersen LR, Dondero TJ, Pappaioanou M: HIV Seroprevalence surveys in drug treatment centers. Public Health Rep 1990, 105:125-130.
18. Centers for Disease Control and Prevention: Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type I infections. MMWR 1989, 38(s-7):1-7.
19. McCray E, Onorato IM, Field Services Branch: Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992, 19:235-241.